River Park Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

River Park Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$36.47 - $42.17 $734,214 - $848,966	-20,132 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $205,971 - $260,069	-4,986 Reduced 19.85%	20,132 $866,000
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $129,856 - $205,556	-3,953 Reduced 13.6%	25,118 $1.24 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $363,687 - $526,355	13,225 Added 83.46%	29,071 $932,000
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $475,063 - $734,462	15,846 New	15,846 $494,000
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $1.04 Million - $1.53 Million	-32,624 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $1.16 Million - $1.29 Million	32,624	32,624 $1.23 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on River Park Advisors, LLC with notifications on news.